Copyright: ©Author(s) 2026.
World J Gastroenterol. Oct 28, 2026; 32(40): 120447
Published online Oct 28, 2026. doi: 10.3748/wjg.120447
Published online Oct 28, 2026. doi: 10.3748/wjg.120447
Figure 4 Least absolute shrinkage and selection operator-Cox regularization for progression-free survival.
A: Ten-fold cross-validation curve showing partial likelihood deviance as a function of log(λ); vertical dashed line indicates λ.min and dot-dashed line indicates λ.1se. Numbers along the top axis represent the count of non-zero coefficients at each λ; B: Coefficient shrinkage paths for all candidate variables; vertical lines correspond to λ.min and λ.1se. Three variables [interleukin (IL)-6 high, IL-10 high, IL-17 high] were retained at λ.1se. (n = 101). PFS: Progression-free survival; CV: Cross validation; EBV: Epstein-Barr virus; IL: Interleukin; PD-L1: Programmed death-ligand 1.
- Citation: Li YC, Pan D, Liu HN, Pei ZC, Li YQ, Han ZX, Liu WL. Baseline cytokines and programmed death-ligand 1 prognostic value in advanced gastric cancer with sintilimab plus chemotherapy. World J Gastroenterol 2026; 32(40): 120447
- URL: https://www.wjgnet.com/1007-9327/full/v32/i40/120447.htm
- DOI: https://dx.doi.org/10.3748/wjg.120447